SYL_MALP2
ID SYL_MALP2 Reviewed; 799 AA.
AC Q8EW18;
DT 25-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT 01-MAR-2003, sequence version 1.
DT 03-AUG-2022, entry version 118.
DE RecName: Full=Leucine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_00049};
DE EC=6.1.1.4 {ECO:0000255|HAMAP-Rule:MF_00049};
DE AltName: Full=Leucyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_00049};
DE Short=LeuRS {ECO:0000255|HAMAP-Rule:MF_00049};
GN Name=leuS {ECO:0000255|HAMAP-Rule:MF_00049}; OrderedLocusNames=MYPE3890;
OS Malacoplasma penetrans (strain HF-2) (Mycoplasma penetrans).
OC Bacteria; Tenericutes; Mycoplasmoidales; Mycoplasmoidaceae; Malacoplasma.
OX NCBI_TaxID=272633;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=HF-2;
RX PubMed=12466555; DOI=10.1093/nar/gkf667;
RA Sasaki Y., Ishikawa J., Yamashita A., Oshima K., Kenri T., Furuya K.,
RA Yoshino C., Horino A., Shiba T., Sasaki T., Hattori M.;
RT "The complete genomic sequence of Mycoplasma penetrans, an intracellular
RT bacterial pathogen in humans.";
RL Nucleic Acids Res. 30:5293-5300(2002).
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-leucine + tRNA(Leu) = AMP + diphosphate + L-leucyl-
CC tRNA(Leu); Xref=Rhea:RHEA:11688, Rhea:RHEA-COMP:9613, Rhea:RHEA-
CC COMP:9622, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57427,
CC ChEBI:CHEBI:78442, ChEBI:CHEBI:78494, ChEBI:CHEBI:456215; EC=6.1.1.4;
CC Evidence={ECO:0000255|HAMAP-Rule:MF_00049};
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00049}.
CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family.
CC {ECO:0000255|HAMAP-Rule:MF_00049}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BA000026; BAC44178.1; -; Genomic_DNA.
DR RefSeq; WP_011077214.1; NC_004432.1.
DR AlphaFoldDB; Q8EW18; -.
DR SMR; Q8EW18; -.
DR STRING; 272633.26453847; -.
DR EnsemblBacteria; BAC44178; BAC44178; BAC44178.
DR KEGG; mpe:MYPE3890; -.
DR eggNOG; COG0495; Bacteria.
DR HOGENOM; CLU_004427_0_0_14; -.
DR OMA; TFMVLAP; -.
DR OrthoDB; 32262at2; -.
DR Proteomes; UP000002522; Chromosome.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR GO; GO:0004823; F:leucine-tRNA ligase activity; IEA:UniProtKB-UniRule.
DR GO; GO:0006429; P:leucyl-tRNA aminoacylation; IEA:UniProtKB-UniRule.
DR Gene3D; 3.40.50.620; -; 2.
DR HAMAP; MF_00049_B; Leu_tRNA_synth_B; 1.
DR InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR InterPro; IPR002300; aa-tRNA-synth_Ia.
DR InterPro; IPR002302; Leu-tRNA-ligase.
DR InterPro; IPR025709; Leu_tRNA-synth_edit.
DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd.
DR InterPro; IPR015413; Methionyl/Leucyl_tRNA_Synth.
DR InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit.
DR PANTHER; PTHR43740; PTHR43740; 2.
DR Pfam; PF08264; Anticodon_1; 1.
DR Pfam; PF00133; tRNA-synt_1; 1.
DR Pfam; PF13603; tRNA-synt_1_2; 1.
DR Pfam; PF09334; tRNA-synt_1g; 1.
DR PRINTS; PR00985; TRNASYNTHLEU.
DR SUPFAM; SSF47323; SSF47323; 1.
DR SUPFAM; SSF50677; SSF50677; 1.
DR TIGRFAMs; TIGR00396; leuS_bact; 1.
DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE 3: Inferred from homology;
KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase;
KW Nucleotide-binding; Protein biosynthesis; Reference proteome.
FT CHAIN 1..799
FT /note="Leucine--tRNA ligase"
FT /id="PRO_0000152049"
FT MOTIF 39..50
FT /note="'HIGH' region"
FT MOTIF 575..579
FT /note="'KMSKS' region"
FT BINDING 578
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00049"
SQ SEQUENCE 799 AA; 93330 MW; 33B62E3CD73D06FE CRC64;
MYNHNLVEKK WRKIWKDSNL HTFKDNLKKP KFYALDMFPY PSGAGLHMGH VKSYTPTDVY
ARFKRYQGYS VLHPMGWDAF GLPAEQFALA TKNHPATFTD QNINNFKLQI DQLGFWFDWN
KEVNTTDPNF YKWTQWIFIK LFENGLAEIK DIDVNWCQEL GTVLANEEVL TDEKGNKVSE
RGKYPVIKKP MKQWVLKITK FADQLIDDLE LTDWTVGLKN IQKKWIGKSI GATVKFKIQN
SDSEIEVFTS RPDTIFGVSF IGLSSDHELV LKEKTKNKKI EAFLNELSSL KEYERTAINV
EKKGVLLDIK AIHPITKQLV PVYVCNYVLS NYGNGAIMGV PAGDKRDYDF AKLFNLEIKE
IIKDHPAPYE EDGIHINSDF LNGLNNEDAI AKIVEYLEKN KIGKKQVNYK LKDWLFSRQR
YWGEPFPVLF DEKGNIIVEK NLPLLLPETN DIKPSGTGES PLANLTEWVN VKIDSKLYRR
ETNTMPQWAG SCWYYLAYLL KDGDSYLPLD SKQAYEIFKR WLPVDIYIGG QEHAVLHLLY
ARFWHKFLHQ INVVPNKEPF YKIINQGMIL VNGEKMSKSK GNVVNPSDFV VSHGADALRL
YMMFMGPITA SLPWEESGID GMYKWVQRVY RLFETKQIDK NFNDENLEKK YHQFVKKASE
FMENFDFNLV ISEMMIFINE CYKYEKINYD YMLNFCVILS CFAPFITEEI NEVFLKNKKF
ISDNLWPKYD EKKIVETTIK IPVQINGKIR EVLEINLGAT QKDVVDLAIK NEKIIKWIEN
KKIVKEIYIE NKILNLIIK